A conditional contribution of mast cells to malignant pleural effusion

A. D. Giannou, Z. Prijovic, A. Marazioti, M. Spella, C. Kairi, I. Giopanou, V. Papaleonidopoulos, D. Kardamakis, I. Kalomenidis, G. T. Stathopoulos (Patras, Athens, Greece)

Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Session: Fundamental biology of malignant pleural effusions
Session type: Oral Presentation
Number: 1517
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. D. Giannou, Z. Prijovic, A. Marazioti, M. Spella, C. Kairi, I. Giopanou, V. Papaleonidopoulos, D. Kardamakis, I. Kalomenidis, G. T. Stathopoulos (Patras, Athens, Greece). A conditional contribution of mast cells to malignant pleural effusion. Eur Respir J 2013; 42: Suppl. 57, 1517

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A myeloid NF-κbeta response in malignant pleural effusion
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013

A requirement for kras signaling in malignant pleural effusion
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013

Role of tumor derived versican in experimental malignant pleural mesothelioma
Source: International Congress 2016 – Mesothelioma and pleural disease: from the bench to the bedside
Year: 2016

Recruitment and phenotypic characteristics of interleukin 9−Producing CD4+ T cells in malignant pleural effusion
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013


Solitary fibrous tumour of the pleural: Two malignant cases
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015


Blood-staining of pleural fluid is an inaccurate predictor of pleural malignancy
Source: International Congress 2015 – Malignant pleural effusions and mesothelioma
Year: 2015


Efficacy of cytology, cell blocks and thoracoscopic pleural biopsy in malignant pleural effusion diagnosis
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013

LATE-BREAKING ABSTRACT: Host-environmental IL-1ß drives mutant KRAS-IKKa addiction in malignant pleural effusion
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015

Detection of EpCAM-positive microparticles in pleural fluid: A new approach for the diagnosis of the tumoral origin of pleural effusions
Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management
Year: 2015



An examination of the factors for successful pleurodesis against malignant pleural effusion (MPE)
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016


Lent score validation on patients with malignant pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016

Hemorrhagic malignant pleural effusion: Diagnosis, survival rate, and response to talc pleurodesis
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


A computed tomography score to predict malignant pleural effusions
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013


Diagnostic value of pleural fluid angiopoietin-2 (Ang-2) levels, to differentiate malignant pleural effusions from benign pleural effusions
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016

Yield of pleural cytology and macroscopic pleural invasion in metastatic pleural effusion
Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies
Year: 2014


Medical pleuroscoy, role in undiagnosed pleural effusion and therapy for pneumothorax and recurrent pleural effusion
Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases
Year: 2013


Malignant pleural effusion as the initial manifestation of gynecological malignancies
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016


Role of thoracoscopic pleural lavage and brush in undiagnosed exudative pleural effusion
Source: International Congress 2016 – Malignant pleural disease: diagnosis and management
Year: 2016

Endoscopic and histopathological findings in exudative pleural effusion (PE) of cardiac origin
Source: International Congress 2014 – The planet of the pleura
Year: 2014


High fluorescence cells in pleural fluid. Association with pleural malignancy
Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Year: 2013